Nerve block with liposomal bupivacaine and intravenous analgesia
KY20230829-05
Approved other active
Quick answer
Nerve block with liposomal bupivacaine and intravenous analgesia for Liposomal Bupivacaine is a Approved program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Liposomal Bupivacaine
- Phase
- Approved
- Modality
- other
- Status
- active